Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MDAI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.20
vs -0.03
Q2.23
N/A
-0.17
vs 0.05
Q3.23
N/A
-0.30
vs -0.02
Q4.23
N/A
-0.22
vs -0.06
Q1.24
N/A
-0.19
vs -0.20
Q2.24
N/A
-0.16
vs -0.17
Q3.24
N/A
-0.02
vs -0.30
Q4.24
N/A
-0.06
vs -0.22
Q1.25
N/A
-0.13
vs -0.19
Q2.25
N/A
-0.13
vs -0.16
Sales Growth
YoY
Current
Estimates
Q1.23
-13%
5.1M vs 5.8M
Q2.23
NA
4.3M vs NA
Q3.23
-51%
3.4M vs 7M
Q4.23
-13%
5.3M vs 6.1M
Q1.24
+25%
6.3M vs 5.1M
Q2.24
+76%
7.5M vs 4.3M
Q3.24
+138%
8.2M vs 3.4M
Q4.24
+44%
7.6M vs 5.3M
Q1.25
-17%
5.3M vs 6.3M
Q2.25
-27%
5.5M vs 7.5M
Return on Equity
QoQ
Q1.23
-42%
-0.42
vs -0.14
Q2.23
-51%
-0.51
vs -0.42
Q3.23
-730%
-7.30
vs -0.51
Q4.23
+207%
2.07
vs -7.30
Q1.24
+158%
1.58
vs 2.07
Q2.24
+67%
0.67
vs 1.58
Q3.24
+35%
0.35
vs 0.67
Q4.24
+107%
1.07
vs 0.35
Institutionnal Ownership
QoQ
Q3.23
9
9
vs NA
NA
Q4.23
15
15
vs 9
67%
Q1.24
25
25
vs 15
67%
Q2.24
22
22
vs 25
-12%
Q3.24
23
23
vs 22
5%
Q4.24
27
27
vs 23
17%
globenewswire.com
7 hours ago
globenewswire.com
16 hours ago
globenewswire.com
16 hours ago
seekingalpha.com
19 hours ago
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
NASDAQ
Unprofitable
Unprofitable
0.06 ( 5.08%)
Relative Strenght
14
Volume Buzz
-60%
Earning Acce
Yes
Dist 52w H.
62%Quote Panel
Key Metrics
Relative Strength
MDAI
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
199%2025-Revenue
-221%2025-EPS
71%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
H.C. Wainwright
initialisePrevious: Not converted
2024-07-18
Now: Buy
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How MDAI compares to sector?
MDAI
-1x